Table 2.
Literature review of DR and DM screening.
| (A) Diabetic retinopathy [9–15] | |||
| Region | Country | Commissioning authority | Publication year |
| North America | Canada | Clinical Practice Guidelines Expert Com | 2018 |
| Latin America | LA | AAO PPP | 2019 |
| East Mediterranean | EMR | AAO PPP | 2019 |
| Africa | Kenya | Division on NCD, Kenya | 2017 |
| South-East Asia | India | Indian institute of public health | 2019 |
| Europe | England | NHS DR screening program | 2017 |
| West Pacific | New Zealand | Ministry of health, New Zealand | 2016 |
| International Council of Ophthalmology (ICO) | 2017 | ||
| (B) Diabetes mellitus [26–32] | |||
| Region | Country | Commissioning authority | Publication year |
| North America | USA | ADA | 2019 |
| South America | LA | AAO PPP | 2019 |
| East Mediterranean | Pakistan | WHO CC, Pakistan | 2019 |
| Africa | South Africa | SEMDSA | 2017 |
| South East Asia | India | ICMR | 2018 |
| Europe | - | EASD | 2017 |
| West Pacific | Australia | Diabetes Australia | 2014 |
| Japan | Japan Diabetes Society | 2016 | |
AAO American Academy of Ophthalmology, ADA American Diabetes Association, DR Diabetic retinopathy, EASD European Association for the study of diabetes, ICMR Indian Council of Medical Research, LA Latin America, PPP preferred practice pattern, NCD non-communicable disease, NHS National Health Service, SEMDSA Society of Endocrinology, Metabolism, and Diabetes of South Africa; WHO CC World Health Organization Collaborating Center.